Evidence is still emerging: much of the research is preclinical, so honest expectations and a provider who says so are part of good care
Non solo, lagricoltura moderna deve essere anche in grado di adattarsi ai cambiamenti stagionali e a quelli climatici, una delle pi grandi sfide attuali e che riguarderanno anche il nostro futuro
Battle misconceptions head-on:GLP-1 brands confront bias and stigma with clear, stigma-reducing content proactively addressing emotional and informational hurdles to adherence and long-term engagement
Higher weight loss (1% reduction in weight from baseline was associated with a 3.1% [95% CI, 2.9%-3.2%] lower hazard of discontinuation for patients with type 2 diabetes and a 3.3% [95% CI, 3.2%-3.5%] lower hazard of discontinuation for patients without type 2 diabetes) and higher income (type 2 diabetes only
Semaglutide (Wegovy, Ozempic) Semaglutide is the most established alternative and the one most people consider first